Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-25-000107
Filing Date
2025-10-28
Accepted
2025-10-28 14:07:10
Documents
73
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20250930.htm   iXBRL 10-Q 1582572
2 EX-31.1 bmrn-exx311xq32025.htm EX-31.1 9229
3 EX-31.2 bmrn-exx312xq32025.htm EX-31.2 9242
4 EX-32.1 bmrn-exx321xq32025.htm EX-32.1 5141
  Complete submission text file 0001048477-25-000107.txt   7576835

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20250930.xsd EX-101.SCH 44848
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20250930_cal.xml EX-101.CAL 84663
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20250930_def.xml EX-101.DEF 207384
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20250930_lab.xml EX-101.LAB 573970
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20250930_pre.xml EX-101.PRE 397085
76 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20250930_htm.xml XML 1249498
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 251423294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)